Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates

Wenhui He(Scripps Research Institute), Michael Farzan(Scripps Research Institute)
Immunity
August 1, 2023
Cited by 16


Related Papers